This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Aarhus Universitet, Region Midtjylland. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 71 
1 out of 12 Years Active: 2019
Title: Fredrik Brustad Mellbye: Innovator in Diabetes Treatment
Introduction
Fredrik Brustad Mellbye is a notable inventor based in Aarhus C, Denmark. He has made significant contributions to the field of diabetes treatment through his innovative research and patent.
Latest Patents
Mellbye holds a patent for a method of treating, preventing, or ameliorating type 2 diabetes. This method involves administering an effective amount of cafestol or its derivatives, including esters and salts, to individuals in need. The patent also includes compositions that combine cafestol with additional agents suitable for diabetes treatment. Furthermore, Mellbye's method aims to increase insulin secretion and enhance insulin-dependent glucose uptake.
Career Highlights
Throughout his career, Mellbye has worked with prominent institutions such as Aarhus Universitet and Region Midtjylland. His research has focused on developing effective treatments for diabetes, showcasing his commitment to improving health outcomes.
Collaborations
Mellbye has collaborated with esteemed colleagues, including Søren Gregersen and Per Bendix Jeppesen. These partnerships have contributed to the advancement of his research and the development of innovative solutions in diabetes care.
Conclusion
Fredrik Brustad Mellbye's work in diabetes treatment exemplifies the impact of innovation in healthcare. His patent for cafestol represents a significant step forward in managing type 2 diabetes, highlighting his role as a key inventor in this vital field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile